Inibidores
Os inibidores são moléculas que se ligam a enzimas, receptores ou outras proteínas para reduzir ou bloquear sua atividade biológica. Esses compostos são amplamente utilizados em pesquisas para estudar vias biológicas, entender mecanismos de doenças e desenvolver medicamentos terapêuticos. Os inibidores desempenham um papel crucial no tratamento de várias doenças, incluindo câncer, doenças cardiovasculares e infecções. Na CymitQuimica, oferecemos uma ampla gama de inibidores de alta qualidade para apoiar sua pesquisa em bioquímica, biologia celular e desenvolvimento farmacêutico.
Subcategorias de "Inibidores"
- Angiogénese(2.786 produtos)
- Apoptose(6.265 produtos)
- Ciclo celular/Ponto de verificação(4.798 produtos)
- Cromatina/Epigenética(2.442 produtos)
- Sinalização Citoesquelética(1.530 produtos)
- Dano de DNA/Reparo de DNA(2.966 produtos)
- Endocrinologia/Hormónios(3.708 produtos)
- Enzima(3.669 produtos)
- GPCR/Proteína-G(9.018 produtos)
- Imunologia e Inflamação(3.883 produtos)
- Vírus da Influenza(301 produtos)
- Sinalização JAK/STAT(413 produtos)
- Sinalização MAPK(1.248 produtos)
- Transportador de Membranas/Canal Iónico(3.035 produtos)
- Metabolismo(10.214 produtos)
- Microbiologia/Virologia(7.604 produtos)
- Neurociência(10.384 produtos)
- Outros inibidores(36.027 produtos)
- Oxidação-Redução(42 produtos)
- Sinalização PI3K/Akt/mTOR(1.442 produtos)
- Proteases/Proteassoma(1.726 produtos)
- Células - tronco e Derivados(825 produtos)
- Tirosina Quinase/Adaptador(2.040 produtos)
- Ubiquitinação(1.718 produtos)
Exibir 16 mais subcategorias
Foram encontrados 66684 produtos de "Inibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Antifungal agent 42
Antifungal 42 blocks biofilm formation and inhibits C.albicans' CYP51.Fórmula:C22H20Cl2N4Se2Cor e Forma:SolidPeso molecular:569.25SM-433 hydrochloride
SM-433 hydrochloride, a Smac mimetic & IAP inhibitor, binds XIAP BIR3; potent IC50 <1 μM. (Patent WO2008128171A2)Fórmula:C32H44ClN5O4Cor e Forma:SolidPeso molecular:598.18Fradafiban
CAS:Fradafiban binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM. Fradafiban is a non-polypeptide platelet glycoprotein IIb/IIIa antagonist.Fórmula:C20H21N3O4Pureza:98%Cor e Forma:SolidPeso molecular:367.40PAIR2
CAS:PAIR2 is a selective IRE1α RNase partial antagonist, blocking its ATP site and preventing KIRA from hindering XBP1 splicing.Fórmula:C27H26F4N6O3SCor e Forma:SolidPeso molecular:590.59Minnelide
CAS:Minnelide is a prodrug of triptolide,and shows potent antitumor activity in a number of tumor types.Fórmula:C21H25Na2O10PPureza:98.49% - 99.59%Cor e Forma:SolidPeso molecular:514.37MALT1-IN-5
CAS:MALT1-IN-5 is a potent inhibitor of the MALT1 protease and can be used in cancer research.Fórmula:C17H17ClF2N6O3Cor e Forma:SolidPeso molecular:426.80Guraxetan
Guraxetan can be used in the synthesis of the antitumour drug Lutetium (177Lu) zadavotide Guraxetan.Fórmula:C20H34N4O9Cor e Forma:SolidPeso molecular:474.51GSK-3β inhibitor 6
GSK-3β inhibitor 6 is a highly potent inhibitor of GSK-3β, with an IC50 value of 24.4 μM.Fórmula:C20H17BrN4Cor e Forma:SolidPeso molecular:393.28YM-60828 dihydrochloride
CAS:YM-60828 dihydrochloride is a Factor Xa (FXa) inhibitor and anticoagulant used in the treatment of venous thromboembolic disease.Fórmula:C27H33Cl2N5O5SCor e Forma:SolidPeso molecular:610.55CTX-712
CAS:CTX-712 is a potent inhibitor of cdc2-like kinase ( CLK ). CTX-712 inhibits inhibits cancer survival and cancer cell growth.Fórmula:C19H17FN8O2Cor e Forma:SolidPeso molecular:408.39EF1502 free base
CAS:EF1502 is a potent and selective GABA transporter inhibitor.Fórmula:C22H26N2O2S2Pureza:98%Cor e Forma:SolidPeso molecular:414.58Gly-7-MAD-MDCPT
CAS:<p>Gly-7-MAD-MDCPT: anticancer Camptothecin with IC50 of 10-1000 nM against diverse cancers.</p>Fórmula:C24H22N4O7Cor e Forma:SolidPeso molecular:478.45PDHK-IN-3
PDHK-IN-3 (compound 7) is a potent inhibitor of pyruvate dehydrogenase kinase(PDHK) with IC50s of 0.21 and 1.54 μM for PDHK2 and PDHK4, respectively [1].Fórmula:C17H16N2O2Cor e Forma:SolidPeso molecular:280.32UTPγS trisodium salt
CAS:P2Y2 and P2Y4 receptor agonistFórmula:C9H12N2Na3O14P3SPureza:98%Cor e Forma:SolidPeso molecular:566.15Tuberculosis inhibitor 5
Compound 11i: potent, non-toxic anti-tuberculosis biphenyl analogue.Fórmula:C25H18N2O2SCor e Forma:SolidPeso molecular:410.49MGAT2-IN-1
CAS:MGAT2-IN-1 is an orally active monoacylglycerol acyltransferase (MGAT2)inhibitor (human and mouse MGAT2 with IC50 of 7.8 and 2.4 nM , respectively).Fórmula:C27H21ClF5N7O3SCor e Forma:SolidPeso molecular:654.01Ph-Ph+
Ph-Ph+ is a dimerized phenanthroline derivative with antitumor, antibacterial, and antifungal effects.Fórmula:C24H17N4Cor e Forma:SolidPeso molecular:361.42CPPG
CAS:CPPG: potent group II/III mGlu receptor antagonist, 20x more selective for group III (IC50: 2.2 nM) than II (46.2 nM) in rat cortex.Fórmula:C11H14NO5PCor e Forma:SolidPeso molecular:271.21Anticancer agent 29
<p>Compound E/Z-6f, anticancer, IC50: CDK2 (0.054 μM), CDK1 (0.127 μM), CDK4 (0.129 μM), CDK6 (0.396 μM).</p>Fórmula:C22H15ClFNOCor e Forma:SolidPeso molecular:363.81ATR-IN-14
CAS:ATR-IN-14: potent ATR kinase inhibitor; 98.03% inhibition at 25 nM; IC50 of 64 nM in LoVo cells.Fórmula:C20H20FN7OCor e Forma:SolidPeso molecular:393.42COX-2-IN-10
COX-2-IN-10 is a potent COX-2 inhibitor, reducing IL-6, TNF-α, IL-1β, PGE2 (IC50=2.54 μM), and iNOS expression.Fórmula:C31H32FN5O2SCor e Forma:SolidPeso molecular:557.68Napsagatran hydrate
CAS:Napsagatran hydrate is a novel and specific inhibitor of thrombin.Fórmula:C26H36N6O7SPureza:98%Cor e Forma:SolidPeso molecular:576.66Glutamate-5-kinase-IN-2
Glutamate-5-kinase-IN-2 (compound 54) is a potent G5K inhibitor with 4.2 μM MIC, potential in anti-TB research.Fórmula:C17H10ClFN2Cor e Forma:SolidPeso molecular:296.73AQX-435
CAS:AQX-435 activates SHIP1, inhibits PI3K in BCR signaling, induces apoptosis in B cells, and slows lymphoma growth.Fórmula:C27H34N2O4Cor e Forma:SolidPeso molecular:450.57SOS1-IN-10
SOS1-IN-10 is a potent inhibitor of SOS1 that acts on KRAS G12C-SOS1 (IC50: 13 nM).Fórmula:C22H19F5N4OCor e Forma:SolidPeso molecular:450.4COX-2-IN-9
COX-2-IN-9: potent oral COX-2 blocker, selective over Celecoxib, IC50 10.17 μM, less ulcers, strong anti-inflammatory.Fórmula:C25H23N5O4S2Cor e Forma:SolidPeso molecular:521.61KDM1/CDK1-IN-1
KDM1/CDK1-IN-1 inhibits KDM1 (IC50: 0.096 μM) & CDK1 (IC50: 0.078 μM), blocks HOP-92 G2/M phase, induces apoptosis, toxic to cancer cells.Fórmula:C22H17N5O3SCor e Forma:SolidPeso molecular:431.47Combretastatin A1 phosphate
CAS:Combretastatin A1 phosphate: potent anti-angiogenic and tumor vascular disruptor, with research potential in pancreatic neuroendocrine tumors.Fórmula:C18H22O12P2Cor e Forma:SolidPeso molecular:492.31MMSET-IN-1
CAS:MMSET-IN-1 is an inhibitor of multiple myeloma SET domain (MMSET, aka NSD2/WHSC1) .Fórmula:C18H29N7O5Pureza:98%Cor e Forma:SolidPeso molecular:423.47BXL0124
CAS:BXL0124 is a gemini vitamin D analog which targets CD44-STAT3 signaling and inhibits breast cancer invasion.Fórmula:C32H44F6O4Cor e Forma:SolidPeso molecular:606.68ZK168281
CAS:ZK168281 is a 1α,25(OH)2D3 analog, VDR antagonist with 0.1 nM Kd, and blocks receptor CoA interaction.Fórmula:C32H46O5Pureza:98%Cor e Forma:SolidPeso molecular:510.70EGFR/HER2-IN-6
EGFR/HER2-IN-6 is a dual inhibitor of EGFR, HER2, and DHFR with IC50s: 0.122, 0.078, and 0.585 μM, showing anticancer potential and selectivity.Fórmula:C18H21N5O3SCor e Forma:SolidPeso molecular:387.46CLK1/2-IN-1
CAS:CLK1/2-IN-1 is a CLK1 and CLK2 inhibitor and it also inhibits SRPK1 and SRPK2.Fórmula:C21H20F3N7OPureza:98%Cor e Forma:SolidPeso molecular:443.42RIPK1-IN-14
CAS:RIPK1-IN-14 inhibits RIPK1 with 92 nM IC50 and reduces necrotic apoptosis in U937 cells.Cor e Forma:SoildROPA
CAS:ROPA, a potent PKCalpha and PKCgamma activator, promotes tumor growth through PKC-activation.Fórmula:C28H32O6Pureza:98%Cor e Forma:SolidPeso molecular:464.55MRS2179 tetrasodium hydrate
MRS2179 blocks turkey P2Y1 receptor (Kb 102 nM, pA2 6.99), affects platelet aggregation, and has varying IC50s on P2 receptors.Fórmula:C11H15N5Na4O10P2Cor e Forma:SolidPeso molecular:576.21RTIOX-372
CAS:RTIOX-372 is a potent and selective orexin-1 receptor antagonist.Fórmula:C30H39N5O3Cor e Forma:SolidPeso molecular:517.66Polvitolimod
CAS:Polvitolimod is a TLR7 agonist used to treat infectious disease and cancer.Fórmula:C13H14FN5O4Cor e Forma:SolidPeso molecular:323.28Mesulergine hydrochloride
CAS:5-HT2A and 2C receptor antagonistFórmula:C18H27ClN4O2SPureza:98%Cor e Forma:SolidPeso molecular:398.95Antibacterial agent 118
Antibacterial agent 118, potent against various mycobacteria, has MIC values ranging from 10.2 to 163.0 μM. Useful in TB research.Fórmula:C19H21N5O2SCor e Forma:SolidPeso molecular:383.47LRRK2-IN-2
CAS:LRRK2-IN-2: selective, potent LRRK2 inhibitor, IC50 of 0.6 nM, oral, crosses blood-brain barrier, for Parkinson's research.Fórmula:C23H23Cl2F3N6O2Cor e Forma:SolidPeso molecular:543.37CDK7-IN-18
CAS:CDK7-IN-18: potent, pyrimidine-based CDK7 inhibitor with cancer research potential.Fórmula:C22H24F3N7OSPureza:99.28%Cor e Forma:SolidPeso molecular:491.53Menin-MLL inhibitor 26
CAS:Menin-MLL inhibitor 26: Active reference, inhibits cell growth, used in leukemia research.Fórmula:C27H29F3N6O3SCor e Forma:SolidPeso molecular:574.62SphK2-IN-2
SphK2-IN-2 (21g) is a potent and selective inhibitor of SphK2 (IC50: 0.23 μM).Fórmula:C21H25ClN10OCor e Forma:SolidPeso molecular:468.94Tubulin polymerization-IN-4
CAS:Tubulin polymerization-IN-4: inhibits tubulin (IC50=4.6 μM), blocks G2/M phase, induces apoptosis, hinders cell cloning/migration, damages vasculature.Fórmula:C21H21ClN2O4Cor e Forma:SolidPeso molecular:400.86PF 03709270
CAS:PF 03709270 is an oral prodrug of sulopenem with broad-spectrum antibacterial effects on gram-positive and gram-negative bacteria.Fórmula:C19H27NO7S3Pureza:98%Cor e Forma:SolidPeso molecular:477.61Antitubulin agent 1
Antitubulin agents-1 disrupts microtubules, ups α-tubulin acetylation, and has anticancer properties.Fórmula:C21H19N3O3Cor e Forma:SolidPeso molecular:361.39Fusarochromanone
CAS:Fusarochromanone (FC-101) is a mycotoxin produced by Fusarium oxysporum with potent antiangiogenic, anticancer and antimalarial activities.Fórmula:C15H20N2O4Pureza:95.31% - 96%Cor e Forma:SolidPeso molecular:292.33α-Glucosidase-IN-15
α-Glucosidase-IN-15 (Compound 14B) exhibits potent inhibitory activity against α-glucosidase, with an IC50 value of 3.34 μM.Fórmula:C24H24N2SCor e Forma:SolidPeso molecular:372.53JAK2/FLT3-IN-1 TFA
JAK2/FLT3-IN-1 (TFA), an oral JAK2/FLT3 inhibitor, shows anticancer properties; IC50: JAK2 (0.7 nM), FLT3 (4 nM), JAK1 (26 nM), JAK3 (39 nM).Fórmula:C27H35F4N7O3Cor e Forma:SolidPeso molecular:581.61Revexepride
CAS:Revexepride, a 5-HT4 agonist, may boost CYP3A4, used for treating GERD.Fórmula:C21H32ClN3O4Pureza:98%Cor e Forma:SolidPeso molecular:425.95CL656
CAS:CL656 is a stimulator of interferon genes (STING) activator.Fórmula:C20H21F2N9O9P2S2Pureza:98%Cor e Forma:SolidPeso molecular:695.51CCR4 antagonist 2
CAS:CCR4 antagonist 2 (Compound 31) is a novel potent, orally bioavailable small molecule antagonists of CC chemokine receptor 4 (CCR4) that inhibits TregFórmula:C26H28Cl2N6OPureza:98%Cor e Forma:SolidPeso molecular:511.45KDOAM-25 citrate
CAS:KDOAM-25 citrate inhibits KDM5A/B/C/D (IC50: 71, 19, 69, 69 nM); boosts H3K4 methylation, hinders MM1S cell growth. [1]Fórmula:C21H33N5O9Pureza:98%Cor e Forma:SolidPeso molecular:499.51ERK-IN-2
CAS:ERK-IN-2, an ERK2 inhibitor, exhibits an IC50 value of 1.8 nM. At doses greater than 10 μM, it may induce off-target toxicity and/or activity [1].Fórmula:C16H18ClN5O2Pureza:98%Cor e Forma:SolidPeso molecular:347.80ZK 93426 hydrochloride
CAS:benzodiazepine receptor antagonist,competitiveFórmula:C18H21ClN2O3Pureza:98%Cor e Forma:SolidPeso molecular:348.82NBD-10007
CAS:NBD-10007 is an inhibitor of HIV-1 entry.Fórmula:C20H25ClN4O3SPureza:98%Cor e Forma:SolidPeso molecular:436.96Anticancer agent 30
Anticancer agent 30 (6f-Z), a 3-arylidene-2-oxindole, selectively inhibits CDK2, showing potent anticancer potential.Fórmula:C22H15ClFNOCor e Forma:SolidPeso molecular:363.81UCN-01
CAS:inhibitor of Akt, protein kinase C, PDK1 and cyclin-dependent kinasesFórmula:C28H26N4O4Pureza:98%Cor e Forma:SolidPeso molecular:482.53T-2513 hydrochloride
CAS:T-2513 hydrochloride: selective topoisomerase I inhibitor, binds DNA complex, halts DNA/RNA synthesis, causes cell death.Fórmula:C25H28ClN3O5Cor e Forma:SolidPeso molecular:485.96L-690330 hydrate
L-690330 hydrate inhibits IMPase; Ki: 0.30 μM (human), 0.42 μM (bovine cortex); 0.27 μM (recom. human), 0.19 μM (bovine).Fórmula:C8H14O9P2Cor e Forma:SolidPeso molecular:316.14ACT-281959
CAS:ACT-281959, a prodrug of ACT-246475, is a potent P2Y12 antagonist, better than Clopidogrel, effective orally, and in human trials.Fórmula:C38H55N6O14PCor e Forma:SolidPeso molecular:850.85STAT3-IN-7
CAS:STAT3-IN-7, an orally active aryl sulfonamido azetidine compound, serves as a STAT3 inhibitor with anticancer activities.Fórmula:C30H26F5N5O4SCor e Forma:SolidPeso molecular:647.62GSK866
CAS:GSK866 is a selective glucocorticoid receptor agonist (SEGRA).Fórmula:C23H21Cl2F4N5O3Cor e Forma:SolidPeso molecular:562.34Gamendazole
CAS:Gamendazole is a novel drug candidate for male contraception. It has been shown to reduce fertility in male rats without affecting testosterone levels.Fórmula:C18H11Cl2F3N2O2Pureza:98%Cor e Forma:SolidPeso molecular:415.19CDK8-IN-9
CDK8-IN-9, potent CDK8 inhibitor (IC50: 48.6 nM), curbs tumor growth, useful for colorectal cancer research.Cor e Forma:SolidMTL-CEBPA
MTL-CEPBA is a small activating RNA that targets C/EBPα upregulation and exhibits anti-inflammatory and anti-cancer effects.Cor e Forma:SolidSHR0687
CAS:SHR0687: potent KOR agonist, selective, favorable PK, effective in rat pain model, minimal BBB penetration, less CNS side effects.Fórmula:C39H60N8O5Cor e Forma:SolidPeso molecular:720.94AS1940477
CAS:<p>AS1940477 selectively inhibits p38 MAPK α/β, blocks proinflammatory cytokines in cells, and has anti-inflammatory effects in rats.</p>Fórmula:C24H22FN5O2Cor e Forma:SolidPeso molecular:431.46PTP1B-IN-18
PTP1B-IN-18 is an orally active, fully mixed protein tyrosine phosphatase 1B (PTP1B) inhibitor (Ki: 35.2 μM).PTP1B-IN-18 can be used to study type 2 diabetes.Fórmula:C26H19N3O4SCor e Forma:SolidPeso molecular:469.51HIV-1 inhibitor-13
HIV-1 inhibitor-13: oral NNRTI, IC50=0.14μM for HIV-1 RT, effective on resistant strains (EC50=2.85-18nM).Fórmula:C30H32N6O3Cor e Forma:SolidPeso molecular:524.61EGFR-IN-3
EGFR-IN-3 is an EGFR inhibitor with antitumor activity.EGFR-IN-3 inhibits EGFRwt-TK, induces apoptosis (cell death), and can block cells in the G2/M phase.Fórmula:C24H18F4N6O2SPureza:98.1%Cor e Forma:SolidPeso molecular:530.5TTT 3002
CAS:TTT 3002: oral FLT3 inhibitor for AML research, blocks D835 mutations, potent at 0.2 nM IC50.Fórmula:C27H23N5O3Cor e Forma:SolidPeso molecular:465.50BI-2540
CAS:BI-2540 is a HIV non-nucleoside reverse transcriptase ( NNRT ) inhibitor .Fórmula:C24H15ClF5NO5Cor e Forma:SolidPeso molecular:527.83Oxeclosporin
CAS:Oxeclosporin is a hydroxyethyl derivative of serine(8)-cyclosporine; inhibits proliferation and functions of lymphocytes.Fórmula:C64H115N11O14Cor e Forma:SolidPeso molecular:1262.66LRRK2-IN-5
LRRK2-IN-5 is an oral, BBB-penetrating selective inhibitor for LRRK2 with IC50s: 1.2μM (GS) and 16μM (WT); halts LRRK2 autophosphorylation.Fórmula:C24H26F2N4O2SCor e Forma:SolidPeso molecular:472.55Balanol
CAS:Balanol is an ATP-competitive Protein Kinase C and Protein Kinase A inhibitor.Fórmula:C28H26N2O10Cor e Forma:SolidPeso molecular:550.51COX-2-IN-13
COX-2-IN-13 is a potent, selective COX-2 inhibitor with 0.98 μM IC50; shows strong anti-inflammatory properties and low acute toxicity.Fórmula:C19H18N2O5SCor e Forma:SolidPeso molecular:386.42Numidargistat
CAS:CB-1158 is a potent and orally bioavailable inhibitor of arginase (IC50s: 86 and 296 nM for recombinant human arginase 1 and 2).Fórmula:C11H22BN3O5Pureza:98%Cor e Forma:SolidPeso molecular:287.12AN-12-H5
CAS:AN-12-H5 is an anti-enteroviral compound that targets the replication process of PV and EV71 viruses.Fórmula:C24H23N3O4S3Cor e Forma:SolidPeso molecular:513.65Acetylpepstatin
CAS:Acetylpepstatin is an inhibitor of HIV-1 protease, HIV-2 protease, aspartyl protease.Fórmula:C33H61N5O11Pureza:98%Cor e Forma:SolidPeso molecular:703.875HMG499
CAS:HMG499 inhibits HMG-CoA reductase (IC50: 0.41μM), reduces statin-induced HMGCR, lowers cholesterol, and lessens atherosclerosis.Fórmula:C33H54O3Pureza:98%Cor e Forma:SolidPeso molecular:498.78Pexacerfont
CAS:Pexacerfont (BMS-562086) is a selective antagonist of the corticotropin-releasing factor receptor (IC50: 6.1±0.6 nM for the human CRF1 receptor).Fórmula:C18H24N6OPureza:99.77%Cor e Forma:SolidPeso molecular:340.42NTU281
CAS:NTU281 inhibits transglutaminase-2, lowers creatinine in diabetic rats, reduces proteinuria, and fights glomerulosclerosis.Fórmula:C25H31N2O6SCor e Forma:SolidPeso molecular:487.59Complex III-IN-1
Complex III-IN-1 inhibits complex III, has antifungal properties, and an EC50 of 18.53 mg/L against S. sclerotiorum.Fórmula:C14H20ClNO2S2Cor e Forma:SolidPeso molecular:333.9FMK-MEA
CAS:FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor.Fórmula:C21H26FN5O2Pureza:98%Cor e Forma:SolidPeso molecular:399.46Carumonam Sodium
CAS:Carumonam Sodium is a monobactam, penicillin-binding protein inhibitor. It is used as antibacterials.Fórmula:C12H12N6Na2O10S2Pureza:98%Cor e Forma:SolidPeso molecular:510.37BM635 hydrochloride (1493762-74-5 free base)
BM635 hydrochloride is an MmpL3 inhibitor with outstanding anti-mycobacterial activity (MIC50: 0.12 μM against M. tuberculosis H37Rv).Fórmula:C25H30ClFN2OPureza:98%Cor e Forma:SolidPeso molecular:428.97LRRK2-IN-3
CAS:LRRK2-IN-3: potent, selective oral LRRK2 blocker, BBB-penetrant, IC50 of 0.6 nM in hPBMCs, for Parkinson's research.Fórmula:C25H29ClF2N6O2Cor e Forma:SolidPeso molecular:518.99Beclabuvir
CAS:Beclabuvir blocks HCV NS5B polymerase at thumb site 1, effective on genotypes 1, 3, 4, 5 with IC50 <28 nM.Fórmula:C36H45N5O5SPureza:99.87% - 99.93%Cor e Forma:SolidPeso molecular:659.84PD-1/PD-L1-IN-17
<p>PD-1/PD-L1-IN-17 (Compound P20) is a potent PD-1/PD-L1 inhibitor (IC50: 26.8 nM).</p>Fórmula:C23H20ClN3O4Cor e Forma:SolidPeso molecular:437.88KY-02327 acetate
KY-02327 acetate inhibits Dvl-CXXC5, stabilizes Wnt/β-catenin signaling, and enhances osteoblast differentiation.Fórmula:C22H31N3O6Cor e Forma:SolidPeso molecular:433.5Antibiotic LL Z1640-2
CAS:Antibiotic LL Z1640-2 is an inhibitor against the TAK1 activity.Fórmula:C19H22O7Cor e Forma:SolidPeso molecular:362.38O4
CAS:O4 is a novel stabilizer of amyloid- fibrils. O4 used for accelerating the formation of end-stage mature fibrils.Fórmula:C24H15NO7Pureza:98%Cor e Forma:SolidPeso molecular:429.38PDE-I2
CAS:PDE-I2 is a parasite schizogony inhibitor.Fórmula:C25H23N5O8Cor e Forma:SolidPeso molecular:521.48AEP-IN-1
APE-IN-1, a potent AEP inhibitor (IC50: 89 nM), aids Alzheimer's diagnosis and drug research.Fórmula:C18H27N3O3Cor e Forma:SolidPeso molecular:333.43LSD1-IN-15
LSD1-IN-15 inhibits LSD1, MAO-A/B with IC50s: 0.149, 0.028, 0.327 μM; arrests LNCaP cancer cell growth, IC50 9.9 μM.Fórmula:C22H20N2OCor e Forma:SolidPeso molecular:328.41BACE1-IN-2
CAS:BACE1-IN-2 is a BACE1 inhibitor (IC50: 22 nM).Fórmula:C19H15F4N5O2Pureza:98%Cor e Forma:SolidPeso molecular:421.35TAS05567
CAS:TAS05567 is a potent, highly selective, and ATP-competitive Syk inhibitor (IC50: 0.37 nM).Fórmula:C21H29N9O2Pureza:98%Cor e Forma:SolidPeso molecular:439.51GNE684
CAS:GNE684 inhibits RIP1; Ki app: 21 nM (human), 189 nM (mouse), 691 nM (rat).Fórmula:C23H24N6O3Pureza:98%Cor e Forma:SolidPeso molecular:432.48
